Researchers May Have Identified Somatic Driver Alterations That Are Predictive Of Distant Recurrence In Certain Patients With Breast Cancer.

MedPage Today (6/15, Ingram) reported that “in sequencing over 500 early estrogen receptor (ER)-positive/HER2-negative breast cancers from a large randomized trial, researchers may have identified somatic driver alterations that are predictive of distant...